title: Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma.
authors.forename: S
authors.initials: S
authors.lastname: Brugnatelli
authors.forename: A
authors.initials: A
authors.lastname: Riccardi
authors.forename: G
authors.initials: G
authors.lastname: Ucci
authors.forename: M
authors.initials: M
authors.lastname: Petrini
authors.forename: M
authors.initials: M
authors.lastname: Giordano
authors.forename: L
authors.initials: L
authors.lastname: Barbarano
authors.forename: C
authors.initials: C
authors.lastname: Bergonzi
authors.forename: A
authors.initials: A
authors.lastname: De Paoli
authors.forename: L
authors.initials: L
authors.lastname: Cavanna
authors.forename: E
authors.initials: E
authors.lastname: Ascari
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D010865:Pilot Projects; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D018931:Antineoplastic Agents, Hormonal; D011241:Prednisone; D015255:Idarubicin